These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23651089)

  • 21. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput screening of metalloproteases using small molecule microarrays.
    Uttamchandani M
    Methods Mol Biol; 2010; 632():203-19. PubMed ID: 20217580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Working with small molecules: rules-of-thumb of "drug likeness".
    Zhang MQ
    Methods Mol Biol; 2012; 803():297-307. PubMed ID: 22065233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selecting the right compounds for screening: does Lipinski's Rule of 5 for pharmaceuticals apply to agrochemicals?
    Tice CM
    Pest Manag Sci; 2001 Jan; 57(1):3-16. PubMed ID: 11455629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
    J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
    [No Abstract]   [Full Text] [Related]  

  • 26. Ask the experts: increasing and maintaining productivity in the bioanalytical laboratory.
    Beato BD; Briscoe C; Rajarao J; Sangster T
    Bioanalysis; 2013 Jul; 5(14):1715-22. PubMed ID: 23862703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for polymorphs on polymer microarrays.
    Liberski AR; Tizzard GJ; Diaz-Mochon JJ; Hursthouse MB; Milnes P; Bradley M
    J Comb Chem; 2008; 10(1):24-7. PubMed ID: 18166017
    [No Abstract]   [Full Text] [Related]  

  • 28. Combinatorial biosynthesis for drug development.
    Menzella HG; Reeves CD
    Curr Opin Microbiol; 2007 Jun; 10(3):238-45. PubMed ID: 17553731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The graphical representation of ADME-related molecule properties for medicinal chemists.
    Ritchie TJ; Ertl P; Lewis R
    Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond.
    Abad-Zapatero C
    Drug Discov Today; 2007 Dec; 12(23-24):995-7. PubMed ID: 18061876
    [No Abstract]   [Full Text] [Related]  

  • 32. To screen or not to screen: an impassioned plea for smarter chemical libraries to improve drug lead finding.
    Lushington G; Chaguturu R
    Future Med Chem; 2014 Apr; 6(5):497-502. PubMed ID: 24649953
    [No Abstract]   [Full Text] [Related]  

  • 33. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM; Oprea TI
    Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro methods to assess drug precipitation.
    Dai WG
    Int J Pharm; 2010 Jun; 393(1-2):1-16. PubMed ID: 20347943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
    Blum LC; Reymond JL
    J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicinal Chemistry Aware Database GDBMedChem.
    Awale M; Sirockin F; Stiefl N; Reymond JL
    Mol Inform; 2019 Aug; 38(8-9):e1900031. PubMed ID: 31169974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of screening libraries based on the muurolane natural product scaffold.
    Barnes EC; Choomuenwai V; Andrews KT; Quinn RJ; Davis RA
    Org Biomol Chem; 2012 May; 10(20):4015-23. PubMed ID: 22422350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting serpins in high-throughput and structure-based drug design.
    Chang YP; Mahadeva R; Patschull AO; Nobeli I; Ekeowa UI; McKay AR; Thalassinos K; Irving JA; Haq I; Nyon MP; Christodoulou J; Ordóñez A; Miranda E; Gooptu B
    Methods Enzymol; 2011; 501():139-75. PubMed ID: 22078534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiochemical property space distribution among human metabolites, drugs and toxins.
    Khanna V; Ranganathan S
    BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S10. PubMed ID: 19958509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.